IPP Bureau
Getinge to boost scalability and deepen healthcare access in India
By IPP Bureau - April 01, 2023
Getinge has a strong market share in India within several product segments
HSBC acquisition of SVB UK to unleash new opportunities in biotech sector, finds GlobalData
By IPP Bureau - April 01, 2023
SVB Financial Group and its subsidiaries were involved in over $1.4 billion in total venture financing raised from 2010 to 2022 for drug development
ProBioGen delivers strong 2022 performance
By IPP Bureau - April 01, 2023
ProBioGen was able to carry on its rapid growth trajectory by completing a significantly increased number of projects.
Lonza completes drug product manufacturing line in Visp
By IPP Bureau - March 31, 2023
This expansion follows the groundbreaking of a large-scale commercial drug product facility in Stein (CH), in another milestone for Lonza’s Drug Product Services (DPS) offering
Evonik starts construction of US$220 million lipid innovation center in Lafayette
By IPP Bureau - March 31, 2023
Cooperative agreement with U.S. Government to advance U.S. biopharma industry and ensure pandemic preparedness
MMP Industries wins its first commercial order from Aurobindo Pharma
By IPP Bureau - March 31, 2023
The order marks a significant milestone for MMP Industries that will contribute to the company's revenue in the coming financial year
Alembic receives USFDA final approval for Brimonidine Tartrate Ophthalmic Solution
By IPP Bureau - March 31, 2023
Brimonidine Tartrate Ophthalmic Solution is an alpha adrenergic receptor agonist indicated for the reduction of elevated intraocular pressure
Abberior installs STED Microscope at MBC BioLabs
By IPP Bureau - March 31, 2023
Stedycon Sted super-resolution fluorescence microscope
Granules India receives ANDA approval for Gabapentin Tablets
By IPP Bureau - March 30, 2023
Gabapentin Tablets are indicated for management of postherpetic neuralgia in adults
Heartfulness signs hits a new milestone by signing an MoU with AIIMS
By IPP Bureau - March 30, 2023
CAHO and Dozee join hands to discuss emerging role of AI in healthcare
By IPP Bureau - March 30, 2023
70+ CXOs from leading healthcare institutions across India attended the confluence at Mumbai
MPP signs sublicences with Aurobindo, Cipla and Viatris to produce generic versions of HIV prevention medicine
By IPP Bureau - March 30, 2023
Licences should enable potentially millions of people living in areas most impacted by HIV to access this innovative prevention medicine through low-cost generic manufacturers
Granules India inaugurates packaging facility in Virginia
By IPP Bureau - March 30, 2023
The facility is over 79,000 square feet and is equipped with packaging lines
Dr. Moopen’s Family increases 4% stake for Rs. 460 crore in Aster DM Healthcare
By IPP Bureau - March 29, 2023
The increase of stake in Aster DM Healthcare is a reiteration of the confidence in the business across geographies
Zydus receives final approval from USFDA for Loperamide Hydrochloride Capsules
By IPP Bureau - March 29, 2023
Loperamide Hydrochloride Capsules USP, 2 mg had annual sales of US $34.7 million in the United States
